T2* Cardiac MRI Screening of Highly Transfused Patients With Myelodysplastic Syndrome
- Male or Female patients will need documentation of diagnosis of Myelodysplastic
Syndrome by previous bone marrow exam
- Male or female patients with MDS who have received at least 50 units of Red Blood
- Serum ferritin > 1,000
- Written informed consent by the patient.
- Contraindication to MRI, including cardiac pacemaker, brain aneurysm clip, implanted
neurostimulator, insulin pump, cochlear implant, metal slivers in the eyes,
intrauterine device or any other MRI incompatible metal implants or intractable
Type of Study:
Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Screening
To evaluate the incidence of clinically significant cardiac iron overload in heavily transfused MDS patients using T2* MRI.
Outcome Time Frame:
A single T2* MRI will be performed on eligible patients.
Eric Feldman, M.D.
Weill Medical College of Cornell University
United States: Institutional Review Board
- Myelodysplastic Syndrome (MDS)
- Myelodysplastic Syndromes
|Weill Medical College of Cornell University
||New York, New York 10021